









































































































































































































































































































































































































































































































































Quarter 1     Quarter 2        Quarter 3  Quarter 4 Quarter 1 Quarter 2  Quarter 3 Quarter 4   Quarter 1 p-value
Medications/Diagnosis
   Medicatons
     H2 Receptors/PPI, N(%) 21 (81) 41 (73) 49 (78) 67 (77) 42 (71) 53 (80) 65 (81) 48 (71) 73 (76) 0.86
     Statins/Antihyperlipidemics, N(%) 9 (35) 16 (29) 19 (30) 26 (30) 12 (20) 34 (52) 22 (28) 21 (31) 23 (24) 0.56
  Opiates/Pain Medications (prescription), N(% 3 (12) 7 (13) 9 (14) 11 (13) 5 (8) 10 (13) 6 (9) 19 (20) 19 (20) 0.58
     Antidepressants/Antianxiety, N(%) 12 (46) 32 (57) 29 (46) 36 (41) 27 (46) 23 (35) 50 (63) 25 (37) 44 (46) 0.54
     Pain Medications (over the counter), N(%) 11 (42) 22 (42) 17 (37) 18 (33) 9 (31) 5 (71) 12 (40) 11 (39) 10 (38) 0.97
   Diagnosis
     Anxiety 8 (31) 16 (29) 12 (19) 26 (30) 13 (22) 12 (18) 21 (26) 18 (26) 20 (21) 0.37
HADS anxiety, mean (SD) 8.3 (4.3) 9.0 (4.6) 8.3 (5.0) 8.7 (4.9) 8.7 (4.9) 8.4 (4.7) 9.3 (4.3) 8.4 (4.9) 8.9 (5.1) 0.63










Pre-COVID    
N (%)




   Medicatons
     H2 Receptors/PPI 217 (75) 244 (77%) 0.58
     Statins/Antihyperlipidemics 82 (28%) 102 (32%) 0.26
     Opiates/Pain Medications (prescription) 41 (14%) 42 (13%) 0.7
     Antidepressants/Antianxiety 136 (47%) 143 (45%) 0.54
     Pain Medications (over the counter) 77 (37%) 39 (42%) 0.44
   Diagnosis
     Anxiety 74 (26%) 73 (23%) 0.41
     Depression 80 (28%) 73 (23%) 0.14
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Appendix A:        Hospital Anxiety and Depression Scale (HADS)© 
 
Appendix B:       Gastroparesis Registry 3 Baseline History Form 
          (Confidential – not for sharing or citation) 
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Hospital Anxiety and Depression Scale (HADS) 
 
Tick the box beside the reply that is closest to how you have been feeling in the past week. 
Don’t take too long over you replies: your immediate is best. 
D A  D A  
  I feel tense or 'wound up':   I feel as if I am slowed down: 
 3 Most of the time 3  Nearly all the time 
 2 A lot of the time 2  Very often 
 1 From time to time, occasionally 1  Sometimes 
 0 Not at all 0  Not at all 
      
  I still enjoy the things I used to 
enjoy: 
  I get a sort of frightened feeling like 
'butterflies' in the stomach: 
0  Definitely as much  0 Not at all 
1  Not quite so much  1 Occasionally 
2  Only a little  2 Quite Often 
3  Hardly at all  3 Very Often 
      
  I get a sort of frightened feeling as if 
something awful is about to 
happen: 
  
I have lost interest in my appearance: 
 3 Very definitely and quite badly 3  Definitely 
 2 Yes, but not too badly 2  I don't take as much care as I should 
 1 A little, but it doesn't worry me 1  I may not take quite as much care 
 0 Not at all 0  I take just as much care as ever 
      
  I can laugh and see the funny side 
of things: 
  I feel restless as I have to be on the 
move: 
0  As much as I always could  3 Very much indeed 
1  Not quite so much now  2 Quite a lot 
2  Definitely not so much now  1 Not very much 
3  Not at all  0 Not at all 
  Worrying thoughts go through my 
mind: 
  I look forward with enjoyment to 
things: 
 3 A great deal of the time 0  As much as I ever did 
 2 A lot of the time 1  Rather less than I used to 
 1 From time to time, but not too often 2  Definitely less than I used to 
 0 Only occasionally 3  Hardly at all 
      
  I feel cheerful:   I get sudden feelings of panic: 
3  Not at all  3 Very often indeed 
2  Not often  2 Quite often 
1  Sometimes  1 Not very often 
0  Most of the time  0 Not at all 
      
  I can sit at ease and feel relaxed:   I can enjoy a good book or radio or TV 
program: 
 0 Definitely 0  Often 
 1 Usually 1  Sometimes 
 2 Not Often 2  Not often 





17BH - Baseline Medical HistoryBH121 Dec 18 BH - Baseline Medical History
Purpose:  To collect baseline history information about the patient to screen for potential enrollment into the Gas-
troparesis Registry 3.
When:  Screening visit s.
Administered by:  Clinical Coordinator, reviewed by Study Physician.
Respondent: Patient.
Instructions:  Collect information by interview and/or chart review.  Enter “m”  if the patient does not know the 
answer to a query.  If a    is checked for any item, further review is necessary by the study physician who will
determine whether the diagnosis or condition in the  item renders the patient ineligible for or unlikely to 
comply with the requirements of the GpR 3 study.  If a   or   is checked for any item, the patient is ineligi-
ble and cannot enroll in the Gastroparesis Registry 3 unless the item can be resolved within the 112 day screening
window.  The BH form cannot be keyed to the data system if there is a         or         item present.  The form
should be retained in a study file for further evaluation as appropriate.




4. Visit date (date this form is initiated):
yearmonday
5. Visit code:   s
6. Form & revision:   1  h  b
7. Study:
B.  Gastroparesis history
8. Has the patient had symptoms of
gastroparesis of at least 12 weeks
duration (do not have to be contiguous)
with varying degrees of nausea,




These next 6 questions ask about the period in the
past when your gastroparesis symptoms started
9. Date symptoms of gastroparesis or
functional dyspepsia started:
yearmonday
10. Which best describes the onset of
gastroparesis or functional dyspepsia
symptoms (check only one):
Acute start ( 1)
Insidious or gradual ( 2)
Other (specify) ( 3)
specify
11. Did the patient have an initial infectious





12. Specify infectious symptoms (check only one):
Upper respiratory flu-like illness
 (fever, cough, body aches): ( 1)
Food-poisoning like symptoms
 (nausea, vomiting after eating bad 
 food): ( 2)
Gastroenteritis
 (nausea, vomiting, diarrhea): ( 3)
Other (specify): ( 4)
specify
Gastroparesis Registry 3
GpR 3        7
Keyed: (      )
GpR 3Form BH
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13. What prompted the evaluation for
gastroparesis (check all that apply)
a. Nausea: ( 1)
b. Vomiting: ( 1)
c. Bloating: ( 1)
d. Early satiety (a sense that your stomach
is full after eating only a small amount
of food): ( 1)
e. Postprandial fullness (a sense of
fullness after the meal): ( 1)
f. Abdominal pain: ( 1)
g. Diarrhea: ( 1)
h. Constipation: ( 1)
i. Anorexia (loss of appetite): ( 1)
j. Weight loss: ( 1)
k. Weight gain: ( 1)
l. Gastroesophageal reflux symptoms
such as heartburn: ( 1)
m. Problems with the management of
diabetes or glycemic control: ( 1)
n. Other (specify): ( 1)
specify
14. Select the one predominant symptom
listed in item 13 (a through n) that
prompted the evaluation for gastroparesis:
a-nThese next 3 questions ask about your
current symptoms of gastroparesis.
15. Which best describes the patient’s current
nature of gastroparesis symptoms
(check only one):
Chronic symptoms, but stable severity
of symptoms ( 1)
Chronic symptoms, but progressive
worsening of symptoms ( 2)
Chronic symptoms, but with some
improvement over time ( 3)
Chronic symptoms with periodic
exacerbations with worsening of
symptoms ( 4)
Cyclic pattern of exacerbations with
periods of feeling well in between ( 5)
Asymptomatic ( 6)
Other (specify): ( 7)
specify
16. Which best describes the current
gastroparesis severity (check only one):
(Grade 1) Mild gastroparesis:
Symptoms mild to moderate and
relatively controlled.  Able to maintain
weight and nutrition on a regular diet. ( 1)
(Grade 2) Compensated gastroparesis:
Moderate symptoms with only partial
control with use of daily medications.
Able to maintain nutrition with dietary
adjustments. ( 2)
(Grade 3) Gastroparesis with gastric
failure:  Refractory symptoms that are
not controlled, ER visits, frequent
doctor visits or hospitalizations and/or
inability to maintain nutrition via oral
route. ( 3)
Other (specify): ( 4)
specify
17. What is the investigator’s assessment of
the patient’s current symptoms of
gastroparesis:
None ( 0)




Very severe ( 5)
18. What is the present understanding of the
primary etiology of the patient’s
gastroparesis
a. Diabetes: ( 1)
.
b. Post fundoplication: ( 1)
.
c. Idiopathic: ( 1)
.
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19. Which form of fundoplication was used (check all
that apply)
a. Nissen: ( 1)
b. Dor: ( 1)
c. Toupet: ( 1)
d. Other (specify) ( 1)
specify
C. Family history
20. Have members of the patient’s family




21. Which family members (check all that apply)
a. Brother: ( 1)
b. Sister: ( 1)
c. Mother: ( 1)
d. Father: ( 1)
e. Son: ( 1)
f. Daughter: ( 1)
g. Spouse/partner: ( 1)
h. Other (specify) ( 1)
specify
22. Which family members with
gastroparesis also have diabetes (check all that
apply)
a. Brother: ( 1)
b. Sister: ( 1)
c. Mother: ( 1)
d. Father: ( 1)
e. Son: ( 1)
f. Daughter: ( 1)
g. Spouse/partner: ( 1)
h. Other (specify) ( 1)
specify
D. Weight history
23. What is the patient’s current weight
(patient’s report):
lbs
24. What was the patient’s approximate
weight when diagnosed with
gastroparesis or functional dyspepsia
(date in item 9):
lbs
25. How does the patient’s current weight
compare to prior to the start of his/her








26. Weight compared to start of gastroparesis
a. How much more does the patient




b. How much less does the patient weigh
now compared to the start of his/her
gastroparesis:
lbs
27. Weight prior to gastroparesis
a. What is the most the participant has
ever weighed prior to the gastroparesis
diagnosis:
lbs
b. At what age did the patient weigh
the most:
age in years
28. What is the least the patient has ever
weighed since age 18, but prior to the
start of gastroparesis or functional
dyspepsia symptoms:
lbs
29. At what age did the patient weigh the
least since age 18, but prior to the
gastroparesis symptoms:
age in years  
Patient ID:
GpR 3Form BH
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30. Over the last six months, has the patient
gained weight, lost weight, or stayed the
same:
Gained weight ( 1)
Lost weight ( 2)
Stayed the same ( 3)
31. What was the patient’s approximate
weight six months ago:
lbs
32. Review flashcard #7  Which (picture)
best describes your weight pattern over
the past 5 years (check only one):
Up and down, up and down ( 1)
Up gradually ( 2)
Up sharply (gained a lot in a brief
interval) ( 3)
Down gradually ( 4)
Down sharply (lost a lot in a brief
interval) ( 5)
No or minimal change ( 6)
E. Tobacco cigarette smoking history (interview with
patient; not by chart review)
33. Have you ever smoked tobacco cigarettes:
No, never ( 1)
 38.
Yes, in the past but not anymore ( 2)
Yes, currently smoke cigarettes ( 3)
34. Did you smoke cigarettes regularly (“No” means
less than 20 packs of cigarettes in a lifetime or less




35. How old were you when you first started
regular cigarette smoking:
years
36. How old were you when you (last)
stopped smoking cigarettes (code as “n” if the
patient did not stop smoking):
years
37. On the average of the entire time that you
smoked cigarettes, how many cigarettes
did you smoke per day:
cigarettes/day
F. Alcohol consumption (AUDIT-C) history
   (interview with patient; not from chart review) 
38. How often have you had a drink
containing alcohol in the past year




Monthly or less ( 1)
Two to four times a month ( 2)
Two to three times a week ( 3)
Four or more times a week ( 4)
39. How many drinks containing alcohol do
you have on a typical day when you are
drinking  (check only one):
1 or 2 ( 0)
3 or 4 ( 1)
5 or 6 ( 2)
7 to 9 ( 3)
10 or more ( 4)
40. How often have you had six or more
alcoholic drinks on one occasion in the
past year (including beer and wine) (check only
one):
Never ( 0)
Less than monthly ( 1)
Monthly ( 2)
Weekly ( 3)
Daily or almost daily ( 4)
G. Menstrual history
41. Is the patient female: NoYes
( 2)( 1)
 46.
42. Characterize the menstrual history in the
past year (check only one):
Regular periods ( 1)
Irregular periods ( 2)
Rare periods ( 3)




Revision 1 ( ) BH - Baseline Medical History 4 of 17
43. Are gastroparesis symptoms worse




If yes, check all symptoms that are worse around
the time of menstruation (menstrual periods):
a. Nausea: ( 1)
b. Vomiting: ( 1)
c. Bloating: ( 1)
d. Early satiety: ( 1)
e. Postprandial fullness: ( 1)
f. Abdominal pain: ( 1)
g. Diarrhea: ( 1)
h. Constipation: ( 1)
i. Anorexia: ( 1)
j. Weight loss: ( 1)
k. Weight gain: ( 1)
l. Gastroesophageal reflux symptoms: ( 1)
m. Problems with management of
diabetes or glycemic control: ( 1)
n. Other (specify): ( 1)
specify




45. What was the patient’s age at menopause:
age in years
H.  Medical history
 (       means CAUTION; Flags conditions 
that are exclusionary; verify with Study Physician)
46. Has the patient ever been diagnosed with





Type 1: ( 1)
Type 2: ( 2)
Unknown: ( 3)
Other: ( 4)
48. Age when diagnosed with diabetes:
age in years
49. Weight when diagnosed with
diabetes:
lbs





If yes, check all that apply:
a. Retinopathy (eye changes from
diabetes): ( 1)
b. Nephropathy (kidney disease from
diabetes): ( 1)
c. Peripheral neuropathy (numbness
and/or tingling in distal legs and feet
from diabetes): ( 1)




52. Has the patient had prior episodes of
diabetic ketoacidosis (ketones present in
the blood requiring hospitalization):
NoYes
( 2)( 1)
53. Describe the patient’s glucose control in
the past 6 months (interview with patient)
(check all that apply)
a. Well controlled: ( 1)
b. Hypoglycemic events (symptomatic
and/or requiring intervention): ( 1)
c. Glucose levels above 300 mg/dL: ( 1)
d. Postprandial high glucose levels: ( 1)
e. Postprandial low glucose levels: ( 1)
Patient ID:
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54. Has the patient ever been diagnosed with
or treated for any of the following (check all that
apply; source of information can be interview
and/or chart review):
a. Gestational diabetes
(diabetes of pregnancy): ( 1)
b. Pyloric obstruction: ( 1)
c. Intestinal obstruction: ( 1)
d. Inflammatory bowel disease (IBD): ( 1)
e. Irritable bowel syndrome (IBS): ( 1)
f. Eosinophilic gastroenteritis: ( 1)
g. Acute renal failure: ( 1)
h. Acute liver failure: ( 1)
i. Advanced liver disease
(Child’s B or C; a CPT score of
7 or greater): ( 1)
j. Hepatitis B: ( 1)
k. Hepatitis C: ( 1)
l. Peptic ulcer disease: ( 1)
m. GERD: Gastroesophageal reflux
disease: ( 1)
n. Celiac disease: ( 1)
o. Small intestinal bacterial overgrowth
(SIBO): ( 1)
p. Colonic inertia: ( 1)
q. Interstitial cystitis: ( 1)
r. Bladder dysfunction: ( 1)
s. Diverticulosis: ( 1)
t. Endometriosis: ( 1)
u. Blood clots: ( 1)
v. Hemophilia (bleeding disorder): ( 1)
w. Rheumatoid arthritis: ( 1)
x. Scleroderma: ( 1)
y. Systemic lupus erythematosus (lupus
or SLE): ( 1)
z. Collagen vascular disease: ( 1)
aa. Raynaud’s phenomenon: ( 1)
ab. Other unidentified systemic
autoimmune disorder: ( 1)
ac. Thyroid disease
 (hormonal abnormality): ( 1)
ad. Malignancy (cancer): ( 1)
ae. Peripheral neuropathy  (non-diabetic 
numbness or tingling in hands or legs) 
(see 50c for diabetic neuropathy): ( 1)
af. Migraine headaches: ( 1)
ag. Chronic headaches ≥ 15 per month
(other than migraines): ( 1)
ah. Seizure disorder or epilepsy: ( 1)
ai. Chronic fatigue syndrome: ( 1)
aj. Postural orthostatic tachycardia
syndrome (POTS): ( 1)
ak. Hypertension: ( 1)
al. Heart attack, myocardial infarction: ( 1)
am. Coronary artery disease: ( 1)
an. Cerebrovascular disease: ( 1)
ao. Stroke, cerebrovascular accident
(CVA): ( 1)
ap. Hyperlipidemia
 (high cholesterol, high triglycerides): ( 1)
aq. Chronic pancreatitis: ( 1)
ar. Episode(s) of acute pancreatitis: ( 1)
as. How many episodes of acute
pancreatitis has the patient ever had:
1-9
at. Cholelithiasis  (gallstones): ( 1)
au. Gallbladder disease without
gallstones including chronic
cholecystitis, gallbladder dyskinesia: ( 1)
av. Gout: ( 1)
aw. Polycystic ovary syndrome (PCOS): ( 1)
Patient ID:
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ax. Dermatologic disorders: ( 1)
ay. Myopathy: ( 1)
az. Autonomic nervous system
dysfunction: ( 1)
ba. Fibromyalgia: ( 1)
bb. Multiple sclerosis: ( 1)
bc. Parkinson’s disease: ( 1)
bd. ALS: Amyotrophic lateral sclerosis: ( 1)
be. Anorexia: ( 1)
bf. Bulemia: ( 1)
bg. Binge eating: ( 1)
bh. Avoidant/ Restrictive eating disorder
(ARFID): ( 1)
bi. Non-specific eating disorders: ( 1)
bj. Posttraumatic Stress Disorder
(PTSD): ( 1)
bk. Major (clinical) depression requiring
treatment: ( 1)
bl. Schizophrenia: ( 1)
bm. Bipolar disorder: ( 1)
bn. Obsessive compulsive disorder: ( 1)
bo. Severe anxiety disorder requiring
treatment: ( 1)
bp. Personality disorder requiring
treatment: ( 1)
bq. Dyslexia or learning problems
including ADHD (attention deficit
hyperactivity disorder): ( 1)
br. Primary neurologic conditions that
could cause nausea and/or vomiting
such as increased intracranial
pressure, space occupying or
inflammatory/infectious lesions: ( 1)
bs. Chronic renal failure and/or
hemodialysis or peritoneal dialysis: ( 1)
bt. None of the above: ( 1)
55. Has the patient ever had any abdominal








57. Has the patient ever had a
gastroduodenostomy, gastrojejunostomy,
esophagogastrostomy or gastric bypass:
NoYes
( 2)( 1)





59. Has the patient ever had surgical or
endoscopic pyloroplasty or
pyloromyotomy (G-POEM or POP):
NoYes
( 2)( 1)




61. Has the patient ever had stapling or
banding of the stomach:
NoYes
( 2)( 1)
62. Has the patient ever had a Nissen, Dor, or






b. Did current gastroparesis symptoms




63. Has the patient ever had any other
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c. Did the patient’s symptoms that led to
the gallbladder removal improve after
removal of the gallbladder:
NoYes
( 2)( 1)
d. Did current gastroparesis symptoms










b. Did current gastroparesis symptoms
start before or after the appendectomy:
Before ( 1)
After ( 2)






b. Did current gastroparesis symptoms
start before or after the hysterectomy:
Before ( 1)
After ( 2)






b. Did current gastroparesis symptoms
start before or after the C-section:
Before ( 1)
After ( 2)
68. Has the patient visited the Emergency





69. How many times did the patient visit the
Emergency Department for gastroparesis
in the past year:
70. Has the patient been hospitalized for




71. How many times was the patient
hospitalized for gastroparesis in the
past year:
72. Reason(s) for hospitalization
(check all that apply):
a. Nausea: ( 1)
b. Vomiting: ( 1)
c. Abdominal pain: ( 1)
d. Dehydration: ( 1)
e. Hyperglycemia: ( 1)
f. Hypoglycemia: ( 1)
g. GI bleed: ( 1)
h. Other (specify): ( 1)
specify
I. Nutrition and Gastric Electrical Stimulator
     (GES) use
73. Has the patient ever had a formal




74. On most days during the last 6 months,
did the patient follow a gastroparesis




75. Has the patient received total parenteral
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76. What is the patient’s current source of
nutrition (check all that apply):
a. Oral feeding: ( 1)
b. Enteral feeding: ( 1)
c. Parenteral feeding: ( 1)




a. G tube has been in place since:
yearmonth
78. What does the patient use this G tube for ( check
all that apply):
a. Nutrition: ( 1)
b. Hydration: ( 1)
c. Medication: ( 1)
d. Decompression: ( 1)
e. Other (specify): ( 1)
specify




a. J tube has been in place since:
yearmonth
80. What does the patient use this J tube for (check all
that apply):
a. Nutrition: ( 1)
b. Hydration: ( 1)
c. Medication: ( 1)
d. Decompression: ( 1)
e. Other (specify): ( 1)
specify




a. Central line/PICC has been in place
since:
yearmonth
82. What does the patient use this central
line/PICC for (check all that apply):
a. Nutrition: ( 1)
b. Hydration: ( 1)
c. Medication: ( 1)
d. Other (specify): ( 1)
specify





a. Gastric electrical stimulator (GES) has
been in place since:
yearmonth
b. In the patient’s opinion, has the gastric




c. Is the gastric electrical stimulator
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J.  Medication use
84. Has the patient used insulin for diabetes




 (If yes, check all that apply):
a. Insulin glulisine (Apidra): ( 1)
b. Insulin lispro (Humalog): ( 1)
c. Insulin aspart (Novolog): ( 1)
d. Insulin glargine (Lantus): ( 1)
e. Insulin detemir (Levemir): ( 1)
f. Insulin isophane (Humulin N, Novolin
N): ( 1)
85. Has the patient used an insulin pump in








86. Has the patient used any other





 (If yes, check all that apply):
a. Biguanide: Metformin (Glucophage) ( 1)
b. Thiazolidinediones: Pioglitazone
(Actos), Rosiglitazone (Avandia) ( 1)
c. Sulfonylureas (first gen):
Chlorpropamide
(Diabinese),Tolazamide (Tolinase),
Tolbutamide (Orinase) ( 1)




e. Meglitinides: Repaglinide (Prandin),
nateglinide (Starlix) ( 1)
f. Alpha-glucosidase inhibitors: miglitol
(Glycet), acarbose (Precose) ( 1)
g. Injectable GLP analogs and agonists:
Exenatide (Byetta, Bydureon),
Liraglutide (Victoza), Lixisenatide
(Lyxumia), Semaglutide (Ozempic) ( 1)
h. Dipeptidyl peptidase-4 (DPP-4)
inhibitors: Alogliptin (Nesina),
Sitagliptin (Januvia), Saxagliptin
(Onglyza), linagliptin (Tradjenta) ( 1)
i. SGLT-2 inhibitors: Canagliflozin
(Invokana), Empagliflozin (Jardiance),
Dapagliflozin (Farxiga) ( 1)
j. Rosiglitazone Maleate/Glimepiride
(Avandaryl) ( 1)
k. Pramlintide (Symlin) ( 1)
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87. Has the patient taken any





 (If yes or unsure, check all that apply):





sodium [Pravachol]):, ( 1)
b. Bile acid sequestrant (Colestipol
hydrochloride [Colestid]: ( 1)
c. Fibric acid (Gemfibrozil [Lopid],
Fenofibrate [Tricor]): ( 1)
d. Nicotinic acid (Niaspan): ( 1)
e. Other (specify): ( 1)
specify
88. Has the patient taken any
anticoagulant/antiplatelet medications in




 (If yes or unsure, check all that apply):
a. Apixaban (Eliquis): ( 1)
b. Clopidogrel (Plavix): ( 1)
c. Dabigatran (Pradaxa): ( 1)
d. Dipyridamole (Persantine, Aggrenox): ( 1)
e. Enoxaparin (Lovenox): ( 1)
f. Heparin: ( 1)
g. Rivaroxaban (Xarelto): ( 1)
h. Ticlopide (Ticlid): ( 1)
i. Warfarin (Coumadin): ( 1)
j. Other (specify): ( 1)
specify
k. Other (specify): ( 1)
specify
89. Has the patient taken any systemic




 (If yes or unsure, check all that apply):
a. Betamethasone sodium (Celestone): ( 1)
b. Cortisol: ( 1)
c. Cortisone: ( 1)
d. Dexamethasone (Decadron): ( 1)
e. Hydrocortisone (Hydrocortone): ( 1)
f. Methylprednisolone (Solu-Medrol): ( 1)
g. Prednisolone (Prelone): ( 1)
h. Prednisone: ( 1)
i. Triamcinolone (Acetocot, Amcort,
Aristocort, Kenacort): ( 1)
j. Other (specify): ( 1)
specify
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90. Has the patient taken any
cardiovascular/antihypertensive




 (If yes or unsure, check all that apply):
a. Class III antiarrhythmic agent
(Amiodarone [Pacerone]): ( 1)
b. Dihydropyridine calcium channel
blocker (Amlodipine besylate
[Norvasc], Felodipine [Plendil],
Nifedipine [Adalat, Procardia]): ( 1)
c. Beta1-adrenergic blocker (Atenolol
[Tenormin], Metoprolol [Lopressor]: ( 1)
d. Non-selective beta blocker (Carvedilol
[Coreg], Propranolol [Inderal],




[Vasotec], Lisinopril [Prinivil, Zestril],
Ramipril [Altace], Quinapril
[Accupril]): ( 1)
f. Alpha-2 adrenergic agonist (Clonidine
[Catapres]): ( 1)
g. Digoxin (Lanoxin): ( 1)
h. Diltiazem (Cardizem): ( 1)
i. Alpha-1 adrenergic blocker
(Doxazosin [Cardura], Terazosin
[Hytrin]): ( 1)
j. Furosemide (Lasix): ( 1)
k. Hydrochlorothiazide (Esidrix,
HydroDIURIL): ( 1)
l. Hydrochlorothiazide + triamterene
(Dyazide): ( 1)




n. Losartan potassium with
hydrochlorothiazide (Hyzaar): ( 1)
o. Verapamil (Calan): ( 1)
p. Other (specify): ( 1)
specify
q. Other (specify): ( 1)
specify
91. Has the patient taken any estrogen,
progestin, hormone replacement therapy,
or selective estrogen receptor modulators








methyltestosterone (Tylosterone): ( 1)
c. Esterified estrogen (Estratab, Menest): ( 1)
d. Estradiol (Estrace): ( 1)





Decanoate, Kabolin]): ( 1)






h. Combination oral contraceptives
(Alesse, Demulen, Desogen,
Estrostep, Genora, Intercon, Levlen,
Levlite, Levora, Loestrin, Lo-Ovral,
Necon, Nelova, Nordette, Norethin,
Norinyl, Ortho Cyclen, Ortho-Novum,
Ortho Tri-Cyclen, Ovral, Tri-Levlen,
Triphasil, Trivora, Zovia): ( 1)
i. Synthetic anabolic steroids
(Oxandrolone [Oxandrin],
Oxymetholone [Anadrol]): ( 1)
j. Selective estrogen receptor modulator
(Raloxifene [Evista], Tamoxifen
[Nolvadex]): ( 1)
k. Other (specify): ( 1)
specify
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K.  Medication use for gastroparesis symptoms
For items 92-93: Have the patient use flashcard #8
to indicate the duration of use and perceived bene-
fit for gastroparesis symptoms for each medication
he/she uses/used
92. Is the patient currently taking any proton
pump inhibitors, histamine H2 receptor















































94. Has the patient ever had Botox injected







95. Has the patient had botulinum toxin
(Botox) injected into pylorus for his/her
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e. Serotonin (5-HT3) antagonists
(Ondansetron [Zofran], Trop-
isetron [Navoban], Granis-













































97. Is the patient currently using any of the
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98. Is the patient currently taking any pain
relieving, analgesics, non-steroidal
anti-inflammatory, or aspirin containing
medications (non-narcotic) either regular








b. Aspirin - 325 mg:
c. Celecoxib (Celebrex):
d. Ibuprofen (Advil, Motrin):
e. Indomethacin (Indocin):













 (If yes, answer all that apply using flashcard #8):
BenefitDuration
(0-5)(1-5)
a. Acetaminophen (30 mg)/
codeine phosphate
(Tylenol #3):












caffeine (Esgic - Plus):
g. Fentanyl transdermal (Dura-
gesic patch):
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100. Is the patient taking the narcotic pain
medication for (check all that apply)
a. Pain related to his/her gastroparesis
symptoms, including abdominal pain: ( 1)
b. Headache pain: ( 1)
c. Leg pain: ( 1)
d. Back pain: ( 1)
e. Other pain (specify): ( 1)
specify
101. Has the patient taken any of the
following neuropathic pain medications















L.  Alternative therapies for gastroparesis
      symptoms
For items 102-103: Have the patient use flashcard
#8 to indicate the duration of use and perceived
benefit for each alternative therapy they have used
for gastroparesis symptoms.
102.  Has the patient ever used alternative
medicine or complementary medicine
products or procedures for treatment of
his/her symptoms related to gastroparesis 
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103. Does the patient use a cannabis product






(If yes, use flashcard #8 to answer 
items 103 a and b):
a. Duration of use (1-5):
b. Perceived benefit (0-5):
c. How often do you use these cannabis
products:
Rarely (less than once per month) ( 1)
About once per month ( 2)
About once per week ( 3)
Several times a month ( 4)
Several times per week ( 5)
About once per day ( 6)
More than once per day ( 7)
104. Which cannabis products do you use:
(check all that apply)
a. Marijuana (medical use): ( 1)
b. Marijuana (non-medical/recreational
use): ( 1)
c. THC: ( 1)
d. CBD: ( 1)
e. Marinol (Dronabinol) (see also 96h): ( 1)
f. Nabilone (Cesamet): ( 1)
g. Tetrahydrocannabinol (Syndros) (see
also 96t): ( 1)
105. For which reason(s) do you use these
cannabis products: (check all that apply)
a. Recreational: ( 1)
b. Reduce nausea: ( 1)
c. Reduce abdominal pain: ( 1)
d. Improve appetite: ( 1)
e. Other (specify): ( 1)
specify
M.  Administrative information
106. Study Physician PIN:
107. Study Physician signature:
108. Clinical Coordinator PIN:
109. Clinical Coordinator signature:
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Gastroparesis Registry 
Flash Card #7 Which pattern best describes your weight pattern over the past 5 years?
1 Up and down, up and down
2 Up gradually
3 Up sharply (gained a lot ina brief interval)
4 Down gradually
5 Down sharply (lost a lot in abrief interval)
6 No or minimal change
GpRFlash Card 7
Revision 1 ( )
Weight Pattern Over Past 5 Years
(for use with Form B ) 1 of 1
Gastroparesis Registry 
Gastroparesis Medication Use GpRFlash Card 8
Revision 1 ( ) (for use with Form BH) 1 of 1
Flash Card #8 Which BEST DESCRIBES the DURATION ofuse for the medication you took or are taking?




5 More than 2 years
Flash Card #8
Which BEST DESCRIBES the BENEFIT you
received from the medication you took or are
taking for your gastroparesis symptoms?
0 Not taking for gastroparesis symptoms
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Purpose:  To collect follow-up medical information about the patient.
When :  f024, f048, f072, f096, f120, f144.
Administered by:  Clinical Coordinator, reviewed by the Study Physician.
Respondent: Patient.
Instructions:  Collect information by interview and/or chart review.




4. Visit date (date this form is initiated):
yearmonday
5. Visit code:   f
6. Form & revision:   1  h  f
7. Study:
B.  Interval identification
8. Date of last Follow-up Medical History
form  (if this is f024, record date of Baseline History
form):
yearmonday
C.  Gastroparesis evaluation
9. Has the patient had an upper endoscopy
since the date in item 8:
NoYes
( 2)(  * 1)
*Complete the EG form.
10. Has the patient had a gastric emptying
scintigraphy since the date in item 8:
NoYes
( 2)(  * 1)
*Complete the GE form.
11. Since the date in item 8, which best
describes the patient’s symptoms of
gastroparesis (check all that apply):
a. Nausea: ( 1)
b. Vomiting: ( 1)
c. Bloating: ( 1)
d. Early satiety  (a sense that your stomach
is full after eating only a small amount
of food): ( 1)
e. Postprandial fullness (a sense of
fullness after the meal): ( 1)
f. Abdominal pain: ( 1)
g. Diarrhea: ( 1)
h. Constipation: ( 1)
i. Anorexia  (loss of appetite): ( 1)
j. Weight loss: ( 1)
k. Weight gain: ( 1)
l. Gastroesophageal reflux symptoms
such as heartburn: ( 1)
m. Problems with the management of
diabetes or glycemic control: ( 1)
n. Other (specify): ( 1)
specify
o. No symptoms related to gastroparesis: ( 1)
13.
12. Select the predominant symptom listed in
item 11 (a through n):
13. Since the date in item 8, has the patient






Keyed: (          )
GpR 3Form FH
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14. Since the date in item 8, has the patient





a. Number of Emergency room visits due
to gastroparesis symptoms:
15. Since the date in item 8, has the patient





a. Since the date in item 8, how many
times has the patient been admitted to
the hospital for gastroparesis:
16. Reason(s) for hospitalization
(check all that apply):
a. Intractable nausea and vomiting: ( 1)
b. Abdominal pain: ( 1)
c. Dehydration: ( 1)
d. Hyperglycemia: ( 1)
e. GI bleed: ( 1)
f. Other (specify): ( 1)
specify
17. Since the date in item 8, which best
describes the nature of the patient’s
gastroparesis symptoms (check only one):
Chronic symptoms, but stable severity
of symptoms ( 1)
Chronic symptoms, but progressive
worsening of symptoms ( 2)
Chronic symptoms, but with some
improvement over time ( 3)
Chronic symptoms with periodic
exacerbations with worsening of
symptoms ( 4)
Cyclic pattern of exacerbations with
periods of feeling well in between ( 5)
Asymptomatic ( 6)
Other (specify): ( 7)
specify
18. Since the date in item 8, which best
describes the patient’s gastroparesis
severity
(check only one):
(Grade 1) Mild gastroparesis:
Symptoms mild to moderate and
relatively controlled.  Able to maintain
weight and nutrition on a regular diet. ( 1)
(Grade 2) Compensated gastroparesis:
Moderate symptoms with only partial 
control with use of daily medications.
Able to maintain nutrition with dietary 
adjustments. ( 2)
(Grade 3) Gastroparesis with gastric
failure: Refractory symptoms that are 
not controlled.  Having ER visits,
frequent doctor visits or hospitalizations
and/or inability to maintain nutrition
via oral route. ( 3)
Other (specify): ( 4)
specify
D. Tobacco cigarette smoking history
(interview with patient)
19. Since the date in item 8, have you
smoked cigarettes regularly
(‘‘No’’ means less than 1 cigarette a day




20. On average, how many days per week
have you smoked cigarettes:
# days
21. On the days that you smoked, about how
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E. Alcohol consumption (AUDIT-C) since the 
     date in item 8 (interview with patient)
22. Since the date in item 8, how often have
you had a drink containing alcohol




Monthly or less ( 1)
Two to four times a month ( 2)
Two to three times a week ( 3)
Four or more times a week ( 4)
23. Since the date in item 8, how many
drinks of alcohol, beer, or wine have
you had on a typical day when you are
drinking (check only one):
1 or 2 ( 0)
3 or 4 ( 1)
5 or 6 ( 2)
7 to 9 ( 3)
10 or more ( 4)
24. Since the date in item 8, how often have
you had six or more drinks of alcohol,
beer, or wine on one occasion (check only one):
Never ( 0)
Less than monthly ( 1)
Monthly ( 2)
W eekly ( 3)
Daily or almost daily ( 4)
F. Menstrual history
25. Is the patient female: NoYes
( 2)( 1)
32.
26. Characterize the menstrual history since
the date in item 8  (check only one):
Regular periods ( 1)
Irregular periods ( 2)
Rare periods ( 3)
No periods ( 4)
28.
27. Are gastroparesis symptoms worse





If yes, check all symptoms that are worse around
the time of menstruation:
a. Nausea: ( 1)
b. Vomiting: ( 1)
c. Bloating: ( 1)
d. Early satiety: ( 1)
e. Postprandial fullness: ( 1)
f. Abdominal pain: ( 1)
g. Diarrhea: ( 1)
h. Constipation: ( 1)
i. Anorexia: ( 1)
j. Weight loss: ( 1)
k. Weight gain: ( 1)
l. Gastroesophageal reflux symptoms: ( 1)
m. Problems with management of
diabetes or glycemic control: ( 1)
n. Other (specify): ( 1)
specify
28. Has the patient been pregnant since the




a. If yes, what is the status of the
pregnancy:
Still pregnant ( 1)
Delivery of child ( 2)
Miscarriage ( 3)
Abortion ( 4)




30. Is the patient postmenopausal
(surgical or natural): NoYes
( 2)( 1)
32.
31. Since the date in item 8, has the patient
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G. Medical history
32. Is the patient diabetic: NoYes
( 2)( 1)
35.
a. Is this diagnosis of diabetes new since
the date in item 8: NoYes
( 2)( 1)
33. Describe the patient’s glucose control
since the date in item 8  (interview
with patient; check all that apply):
a. Well controlled ( 1)
b. Hypoglycemic events (symptomatic
and/or requiring intervention) ( 1)
c. Glucose levels above 300 mg/dL: ( 1)
d. Episodes of diabetic ketoacidosis: ( 1)
e. Postprandial high glucose levels ( 1)
f. Postprandial low glucose levels ( 1)
34. Since the date in item 8, has the patient
been diagnosed with or treated for any of




If yes, check all that apply:
a. Retinopathy (eye changes from
diabetes): ( 1)
b. Nephropathy (kidney disease from
diabetes): ( 1)
c. Peripheral neuropathy (numbess
and/or tingling in distal legs and feet
from diabetes): ( 1)
35. Since the date in item 8, has the patient
been diagnosed with or treated for any of 
the following (check all that apply; source
of information can be interview
and/or chart review):
a. Gestational diabetes
(diabetes of pregnancy): ( 1)
b. Pyloric obstruction: ( 1)
c. Intestinal obstruction: ( 1)
d. Inflammatory bowel disease (IBD): ( 1)
e. Irritable bowel syndrom (IBS): ( 1)
f. Eosinophilic gastroenteritis: ( 1)
g. Acute renal failure: ( 1)
h. Acute liver failure: ( 1)
i. Advanced liver disease
(Child’s B or C; a CPT score of
7 or greater): ( 1)
j. Hepatitis B: ( 1)
k. Hepatitis C: ( 1)
l. Peptic ulcer disease: ( 1)
m. GERD: Gastroesophageal reflux
disease: ( 1)
n. Celiac disease: ( 1)
o. Small intestinal bacterial overgrowth
(SIBO): ( 1)
p. Colonic inertia: ( 1)
q. Interstitial cystitis: ( 1)
r. Bladder dysfunction: ( 1)
s. Diverticulosis: ( 1)
t. Endometriosis: ( 1)
u. Blood clots: ( 1)
v. Hemophilia  (bleeding disorder): ( 1)
w. Rheumatoid arthritis: ( 1)
x. Scleroderma: ( 1)
y. Systemic lupus erythematosus (lupus
or SLE): ( 1)
z. Collagen vascular disease: ( 1)
aa. Raynaud’s phenomenon: ( 1)
ab. Other unidentified systemic
autoimmune disorder: ( 1)
ac. Thyroid disease
 (hormonal abnormality): ( 1)
ad. Malignancy  (cancer): ( 1)
ae. Peripheral neuropathy (non-diabetic
numbess or tingling in hands or legs)
(see 34c for diabetic neuropathy): ( 1)
af. M igraine headaches: ( 1)
ag. Chronic headaches  15 per month
(other than migraines): ( 1)
Patient ID:
GpR 3Form FH
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ah. Seizure disorder or epilepsy: ( 1)
ai. Chronic fatigue syndrome: ( 1)
aj. Postural orthostatic tachycardia
syndrome (POTS): ( 1)
ak. Hypertension: ( 1)
al. Heart attack, myocardial infarction: ( 1)
am. Coronary artery disease: ( 1)
an. Cerebrovascular disease: ( 1)
ao. Stroke, cerebrovascular accident
(CVA): ( 1)
ap. Hyperlipidemia
 (high cholesterol, high triglycerides): ( 1)
aq. Chronic pancreatitis: ( 1)
ar. Episode(s) of acute pancreatitis: ( 1)
as. Cholelithiasis (gallstones): ( 1)
at. Gallbladder disease without
gallstones including chronic
cholecystitis, gallbladder dyskinesia: ( 1)
au. Gout: ( 1)
av. Polycystic ovary syndrome (PCOS): ( 1)
aw. Dermatologic disorders: ( 1)
ax. Myopathy: ( 1)
ay. Autonomic nervous system
dysfunction: ( 1)
az. Fibromyalgia: ( 1)
ba. Multiple sclerosis: ( 1)
bb. Parkinson’s disease: ( 1)
bc. ALS: Amyotrophic lateral sclerosis: ( 1)
bd. Anorexia: ( 1)
be. Bulemia: ( 1)
bf. Binge eating: ( 1)
bg. Avoidant/ Restrictive eating disorder
(ARFID): ( 1)
bh. Non-specific eating disorders: ( 1)
bi. Major (clinical) depression: ( 1)
bj. Schizophrenia: ( 1)
bk. Bipolar disorder: ( 1)
bl. Obsessive compulsive disorder: ( 1)
bm. Severe anxiety disorder: ( 1)
bn. Personality disorder: ( 1)
bo. Post-traumatic Stress Disorder
(PTSD): ( 1)
bp. Dyslexia or learning problems
including ADHD (attention deficit
hyperactivity disorder): ( 1)
bq. Other (specify): ( 1)
specify
br. None of the above: ( 1)
36. Since the date in item 8, has the patient





(Check all that apply):
a. Total gastric resection: ( 1)
b. Subtotal gastric resection
(vagotomy, antrectomy): ( 1)
c. Stapling or banding of the stomach: ( 1)
d. Gastrojejunostomy: ( 1)
e. Fundoplication for GERD: ( 1)
f. Cholecystectomy
(gall bladder removal): ( 1)
g. Gastrostomy (surgical or endoscopic): ( 1)
h. Jejunostomy: ( 1)
i. Appendectomy: ( 1)
j. Hysterectomy: ( 1)
k. Surgical pyloroplasty or
pyloromyotomy: ( 1)
l. Endoscopic pyloromyotomy (G-POEM
or POP): ( 1)
m. Peroral endoscopic myotomy
(POEM) for esophageal motility
disorder: ( 1)
n. Gastroduodenostomy: ( 1)
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H. Nutrition and gastric electrical stimulator
     (GES) use 
37. What is the patient’s current source of
nutrition  (check all that apply):
a. Oral feeding: ( 1)
b. Enteral feeding: ( 1)
c. Parenteral feeding: ( 1)
38. Since the date in item 8, has the patient
had a formal nutrition consult:
NoYes
( 2)( 1)
39. Since the date in item 8, has the patient
received total parenteral nutrition (TPN):
NoYes
( 2)( 1)
40. Since the date in item 8, has the patient
had any of the following placed:
NoYes
a. G tube: ( 2)( 1)
b. J tube: ( 2)( 1)
c. Central line/PICC: ( 2)( 1)
d. Gastric electrical stimulator: ( 2)( 1)








42. Since the date in item 8, has the patient
had any of the following removed:
NoYes
a. G tube: ( 2)( 1)
b. J tube: ( 2)( 1)
c. Central line/PICC: ( 2)( 1)
d. Gastric stimulator: ( 2)( 1)
I. Medication use
43. Since the date in item 8, has the patient




 (If yes, check all that apply):
a. Insulin glulisine (Apidra): ( 1)
b. Insulin lispro (Humalog): ( 1)
c. Insulin aspart (Novolog): ( 1)
d. Insulin glargine (Lantus): ( 1)
e. Insulin detemir (Levemir): ( 1)
f. Insulin isophane (Humulin N, Novolin
N): ( 1)
44. Since the date in item 8, has the patient
used an insulin pump:
NoYes
( 2)( 1)
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45. Since the date in item 8, has the patient




 (If yes, check all that apply):
a. Biguanide: Metformin (Glucophage) ( 1)
b. Thiazolidinediones: Pioglitazone
(Actos), Rosiglitazone (Avandia) ( 1)
c. Sulfonylureas (first gen):
Chlorpropamide
(Diabinese),Tolazamide (Tolinase),
Tolbutamide (Orinase) ( 1)




e. Meglitinides: Repaglinide (Prandin),
nateglinide (Starlix) ( 1)
f. Alpha-glucosidase inhibitors: miglitol
(Glycet), acarbose (Precose) ( 1)
g. Injectable GLP analogs and agonists:
Exenatide (Byetta, Bydureon),
Liraglutide (Victoza), Lixisenatide
(Lyxumia), Semaglutide (Ozempic) ( 1)
h. Dipeptidyl peptidase-4 (DPP-4)
inhibitors: Alogliptin (Nesina),
Sitagliptin (Januvia), Saxagliptin
(Onglyza), linagliptin (Tradjenta) ( 1)
i. SGLT-2 inhibitors: Canagliflozin
(Invokana), Empagliflozin (Jardiance),
Dapagliflozin (Farxiga) ( 1)
j. Rosiglitazone Maleate/Glimepiride
(Avandaryl) ( 1)
k. Pramlintide (Symlin) ( 1)
l. Other (specify): ( 1)
specify






(If yes or unsure, check all that apply):





sodium [Pravachol]):, ( 1)
b. Bile acid sequestrant (Colestipol
hydrochloride [Colestid]: ( 1)
c. Fibric acid (Gemfibrozil [Lopid],
Fenofibrate [Tricor]): ( 1)
d. Nicotinic acid (Niaspan): ( 1)
e. Other (specify): ( 1)
specify






(If yes or unsure, check all that apply):
a. Apixaban (Eliquis): ( 1)
b. Clopidogrel (Plavix): ( 1)
c. Dabigatran (Pradaxa): ( 1)
d. Dipyridamole (Persantine, Aggrenox): ( 1)
e. Enoxaparin (Lovenox): ( 1)
f. Heparin: ( 1)
g. Rivaroxaban (Xarelto): ( 1)
h. Ticlopide (Ticlid): ( 1)
i. Warfarin (Coumadin): ( 1)
j. Other (specify): ( 1)
specify
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48. Since the date in item 8, has the patient




(If yes or unsure, check all that apply):
a. Betamethasone sodium (Celestone): ( 1)
b. Cortisol: ( 1)
c. Cortisone: ( 1)
d. Dexamethasone (Decadron): ( 1)
e. Hydrocortisone (Hydrocortone): ( 1)
f. Methylprednisolone (Solu-Medrol): ( 1)
g. Prednisolone (Prelone): ( 1)
h. Prednisone: ( 1)
i. Triamcinolone (Acetocot, Amcort,
Aristocort, Kenacort): ( 1)
j. Other (specify): ( 1)
specify
k. Other (specify): ( 1)
specify





(If yes or unsure, check all that apply):
a. Class III antiarrhythmic agent
(Amiodarone [Pacerone]): ( 1)
b. Dihydropyridine calcium channel
blocker (Amlodipine besylate
[Norvasc], Felodipine [Plendil],
Nifedipine [Adalat, Procardia]): ( 1)
c. Beta1-adrenergic blocker (Atenolol
[Tenormin], Metoprolol [Lopressor]: ( 1)
d. Non-selective beta blocker (Caryedilol
[Coreg], Propranolol [Inderal],




[Vasotec], Lisinopril [Prinivil, Zestril],
Ramipril [Altace], Quinapril
[Accupril]): ( 1)
f. Alpha-2 adrenergic agonist (Clonidine
[Catapres]): ( 1)
g. Digoxin (Lanoxin): ( 1)
h. Diltiazem (Cardizem): ( 1)
i. Alpha-1 adrenergic blocker
(Doxazosin [Cardura], Terazosin
[Hytrin]): ( 1)
j. Furosemide (Lasix): ( 1)
k. Hydrochlorothiazide (Esidrix,
HydroDIURIL): ( 1)
l. Hydrochlorothiazide + triamterene
(Dyazide): ( 1)




n. Losartan potassium with
hydrochlorothiazide (Hyzaar): ( 1)
o. Verapamil (Calan): ( 1)
p. Other (specify): ( 1)
specify
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50. Since the date in item 8, has the patient
taken any estrogen, progestin, hormone
replacement therapy, or selective








methyltestosterone (Tylosterone): ( 1)
c. Esterified estrogen (Estratab, Menest): ( 1)
d. Estradiol (Estrace): ( 1)





Decanoate, Kabolin]): ( 1)






h. Combination oral contraceptives
(Alesse, Demulen, Desogen,
Estrostep, Genora, Intercon, Levlen,
Levlite, Levora, Loestrin, Lo-Ovral,
Necon, Nelova, Nordette, Norethin,
Norinyl, Ortho Cyclen, Ortho-Novum,
Ortho Tri-Cyclen, Ovral, Tri-Levlen,
Triphasil, Trivora, Zovia): ( 1)
i. Synthetic anabolic steroids
(Oxandrolone [Oxandrin],
Oxymetholone [Anadrol]): ( 1)
j. Selective estrogen receptor modulator
(Raloxifene [Evista], Tamoxifen
[Nolvadex]): ( 1)
k. Other (specify): ( 1)
specify
l. Other (specify): ( 1)
specify
J. Relevant medication use
 For items 50-58: Have the patient use flashcard
#9a to indicate the frequency of use and flashcard
#9b to indicate the perceived benefit for gas-
troparesis symptoms for each medication he/she
uses/used
51. Since the date in item 8, has the patient
taken any proton pump inhibitors,
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52. Since the date in item 8, has the patient























53. Since the date in item 8, has the patient





a. Perceived benefit (use flashcard #9b):
0-5
b. Number of weeks since last injection:
00-48
54. Since the date in item 8, has the patient















e. Serotonin (5-HT3) antagonists
(Ondansetron [Zofran], Trop-
isetron [Navoban], Granis-

















































55. Since the date in item 8, has the patient



























56. Since the date in item 8, has the patient
taken any pain relieving, analgesics,
non-steroidal anti-inflammatory, or
aspirin containing medications










b. Aspirin - 325 mg:
c. Celecoxib (Celebrex):
d. Ibuprofen (Advil, Motrin):
e. Indomethacin (Indocin):
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57. Since the date in item 8, has the patient








a. Acetaminophen (30 mg)/
codeine phosphate
(Tylenol #3):














caffeine (Esgic - Plus):
h. Fentanyl transdermal (Dura-
gesic patch):














 Note: Participants should not be taking narcotic
medications more than 3 days per week.
58. Is the patient taking the narcotic pain
medication for (check all that apply)
a. Pain related to gastroparesis
symptoms, including abdominal pain: ( 1)
b. Headache pain: ( 1)
c. Leg pain: ( 1)
d. Back pain: ( 1)
e. Other pain  (specify): ( 1)
specify
59. Since the date in item 8, has the patient
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K. Alternative therapies
For item 60: Have the patient use flashcard #9a
to indicate the frequency of use and flashcard #9b
to indicate perceived benefit for gastroparesis
symptoms for each medication he/she uses/used
60. Since the date in item 8, has the patient
used alternative medicine or
complementary medicine products or
procedures for treatment of his/her
symptoms related to gastroparesis









a. Probiotic #1 (specify):
specify
b. Probiotic #2 (specify):
specify
c. Herbal supplement #1
(specify):
specify
d. Herbal supplement #2
(specify):
specify












61. Since the date in item 8, has the patient



















(Syndros) (see also 53t):
62. For which reason(s) do you use these
cannabis products: (check all that apply)
a. Recreational: ( 1)
b. Reduce nausea or vomiting: ( 1)
c. Reduce abdominal pain: ( 1)
d. Improve appetite: ( 1)
e. Other (specify): ( 1)
specify
L. Administrative information
63. Study Physician PIN:
64. Study Physician signature:
65. Clinical Coordinator PIN:
66. Clinical Coordinator signature:
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Gastroparesis Registry 
GpRFlash Card 9
Revision 1 ( )
Gastroparesis Medication Use
(for use with Form H) 1 of 1
Flash Card #9a Which BEST DESCRIBES the FREQUENCY ofuse for the medication you took or are taking?
1 Used only one or two times since the date in item 8
2 Less than once per week
3 About once a week
4 Several times a week
5 About once per day
6 More than once per day
Flash Card #9b
Which BEST DESCRIBES the BENEFIT you
received from the medication you took or are
taking for your gastroparesis symptoms?
0 Not taking for gastroparesis symptoms
1 No or minimal benefit for gastroparesis symptoms
2 Better
3 Much better
4 Worse
5 Much worse
